(Q46779409)

25 December 2017

title

NFAT2 mediates high glucose-induced glomerular podocyte apoptosis through increased Bax expression (English)

1 reference

25 December 2017

author name string

Ruizhao Li

1

1 reference

25 December 2017

Li Zhang

2

1 reference

25 December 2017

Wei Shi

3

1 reference

25 December 2017

Bin Zhang

4

1 reference

25 December 2017

Xinling Liang

5

1 reference

25 December 2017

Shuangxin Liu

6

1 reference

25 December 2017

Wenjian Wang

7

1 reference

25 December 2017

language of work or name

English

0 references

publication date

20 January 2013

1 reference

25 December 2017

Experimental Cell Research

published in

1 reference

25 December 2017

volume

319

1 reference

25 December 2017

issue

7

1 reference

25 December 2017

page(s)

992-1000

1 reference

25 December 2017

Clinical practice. Nephropathy in patients with type 2 diabetes

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Evolving strategies for renoprotection: diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

7 January 2021

The targeted podocyte

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Podocyte loss and progressive glomerular injury in type II diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Podocyte number in normotensive type 1 diabetic patients with albuminuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Induction of heme oxygenase-1 protects against podocyte apoptosis under diabetic conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Apoptosis in the kidneys of patients with type II diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Transcription factors of the NFAT family: regulation and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Manipulating immune responses with immunosuppressive agents that target NFAT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

The transcription factor NFAT3 mediates neuronal survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

NFAT2 is implicated in corticosterone-induced rat Leydig cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

High glucose activates nuclear factor of activated T cells in native vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

The transcription factor NF-ATc is essential for cardiac valve formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Activation of the Ca(2+)/calcineurin/NFAT2 pathway controls smooth muscle cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

GSK-3beta negatively regulates skeletal myotube hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Nuclear factor of activated T cells (NFAT) is a possible target for dexamethasone in thymocyte apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Activation of NFAT signaling in podocytes causes glomerulosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Calcineurin (CN) activation promotes apoptosis of glomerular podocytes both in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Cell death, Bcl-2, Bax, and the cerebellum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Progression of glomerular diseases: is the podocyte the culprit?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Podocytes: gaining a foothold.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.007

10.1016/J.YEXCR.2013.01.007

7 January 2021

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017